Navigation Links
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Date:6/19/2009

WILMINGTON, Mass., June 19, /PRNewswire/ -- NeuroTherm announces the acquisition of the Micron Catheter from private owners in Palm Beach Gardens, Florida on June 17, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )

"This acquisition provides the opportunity to offer our customers another exceptional product," says Larry Davis, V.P. of US Sales for NeuroTherm. NeuroTherm has an established distribution network currently selling a wide range of products to interventional pain specialists in the United States and internationally. "This is a logical expansion of our current product offering; many of our physicians have been waiting for us to provide an epidural catheter as part of our product mix," continues Davis.

The Micron Catheter is used in a procedure called Epidural Lysis of Adhesions; a common interventional pain procedure used to remove scar tissue. The scar tissue which typically result from back surgery, inflame surrounding nerves creating a source of chronic pain.

"The Micron Catheter was particularly interesting to us because of a revolutionary design that includes a continuous coil guide wire and a tip that is not a fused cap. This removes any danger of the tip breaking during procedure," says Bill Rittman, CTO of NeuroTherm. "We are excited about offering this product, along with the opportunity to improve and expand the catheter line going forward."

NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain, including radio frequency generators and related consumables used in the treatment of chronic pain. The company developed the first multi-lesion generator capable of producing multiple level lesions simultaneously. NeuroTherm markets and sells RF products for use in Interventional Pain and Podiatry; Podiatrists use radiofrequency to treat pain associated with Plantar Fasciitis & Neuroma.

NeuroTherm is based in Wilmington, Massachusetts with corporate offices in London, UK and Amsterdam, NL. Additional information about NeuroTherm can be found on at www.neurotherm.com.


'/>"/>
SOURCE NeuroTherm
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Arizona (PRWEB) , ... December 07, 2016 , ... Delete® ... Just in Time For The Holiday Party Season. Save Up To 33% Off Botox® ... Laser Salon is providing the Phoenix Valley with Delightful Deals on Botox® ...
(Date:12/7/2016)... , ... December 07, 2016 , ... "ProBrand Flip allows ... all media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip ... to use drop zones. Editors can select from a variety of flip book animations. ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an ... not a one hour a week showing of hands. “The Road To Restoration” is ... “Perhaps you are familiar with the brass ring that you could reach out for, ...
(Date:12/7/2016)... , ... (PRWEB) December 07, 2016 , ... ... nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded a grant from ... a patient engagement program. New Mexico has more people with cavernous angioma than ...
(Date:12/7/2016)... Warwick, New York (PRWEB) , ... December 07, 2016 , ... ... computer professor at Yale had described him as 'a genius.'" Thus begins "Margaret in ... R. L. Rhyse and published by Wyston Books, Inc. These novels narrate ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 6, 2016 Homozygous Familial Hypercholesterolemia ... Summary Global Markets Direct,s latest Pharmaceutical ... Hypercholesterolemia (HoFH) – Pipeline Review, H2 2016, ... Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape. ... which is caused due to mutation from ...
(Date:12/6/2016)... Dec. 6, 2016 Human Vaccines Market: ... region wise and country wise analysis of the ... manufacturers of human vaccines products, raw material suppliers, ... enter the market. The report provides qualitative ... market. Qualitative analysis comprises market dynamics, trends, product ...
(Date:12/6/2016)...  Nearly 30 million people in the ... diabetes. 1 However, nearly 40% of diabetes patients ... and significant glucose variability. 2 These patients are at ... If left untreated, hyperglycemia can lead to cardiovascular disease, ... 3 As part of Diabetes Awareness ...
Breaking Medicine Technology: